
At NCCN 2026, Dr. Charles Peyton emphasized patient engagement and shared decision-making as expanding treatment options reshape bladder cancer care.

At NCCN 2026, Dr. Charles Peyton emphasized patient engagement and shared decision-making as expanding treatment options reshape bladder cancer care.

Dr. Charles Peyton discusses the growing number of bladder cancer therapies and emphasizes the importance of personalized care and patient education.

Supportive care with ESAs or danazol alongside Jakafi helps myelofibrosis patients with anemia manage symptoms and maintain effective treatment doses.